Jemima Warrack

Jemima Warrack has a diverse work experience spanning over two decades. Jemima is currently employed as the Director of Patient Advocacy at VectivBio AG since June 2021. Prior to this, they founded their own company, J Warrack Ltd, in 2012, where they held the position of Director.

Between 2015 and 2022, Jemima worked at VOZ Advisors as a Consultant (Director), providing their expertise in consulting. In 2018, they briefly worked at Genomics Medicine Ireland, focusing on stakeholder engagement strategy.

In 2014, Jemima served as the Interim Head of Communications at Novo Nordisk. Jemima had previously worked at Voz Advisors, Inc as a Consultant from 2012 to 2013. Before that, they were a contract consultant for AstraZeneca, specializing in payer communications and corporate affairs.

From 2006 to 2011, Jemima worked as a Consultant for Just:: and inVentiv, contributing to the CCA, B2, and Litmus programs. Prior to that, they held the role of Senior Consultant at Chandler Chicco Agency from 2001 to 2006.

Jemima's early career includes a role as an Account Manager at Greenlines Health from 1999 to 2001.

Overall, Jemima Warrack has gained extensive experience in various roles and industries, with a focus on consulting, communications, stakeholder engagement, and patient advocacy.

Jemima Warrack has a degree in Biological Science with a focus on Zoology/Animal Biology from Cardiff University / Prifysgol Caerdydd.